Researcher

Biography

Salim is a Gastroenterologist and Hepatologist and has been lecturing at the UNSW School of Clinical Medicine for over 5 years. I am currently completing a PhD into the gut-liver axis; in particular the relationship between diet-related changes to the gut microbiome and its downstream impact on progression of liver disease and development of liver cancer.


My Qualifications

Gastroenterologist & Hepatologist
Royal...view more

Salim is a Gastroenterologist and Hepatologist and has been lecturing at the UNSW School of Clinical Medicine for over 5 years. I am currently completing a PhD into the gut-liver axis; in particular the relationship between diet-related changes to the gut microbiome and its downstream impact on progression of liver disease and development of liver cancer.


My Qualifications

Gastroenterologist & Hepatologist
Royal Australasian College of Physicians                                                                

 

Gastrointestinal Endoscopist
Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy                    

 

Bachelor of Medicine and Bachelor of Surgery
University of Sydney                                
                                               

 Bachelor of Science (Honours in Biology)
McMaster University, Hamilton Canada     


My Research Activities

Maher S, Kabir A, Behary J, Conway DP et al. New South Wales data linkage study reveals a shift in HCC mortality risk: Time for broader strategies. Cancer Epidemiol. 2024 Dec;93:102690. PMID: 39486273.

Maher S, Rajakapakse J, El-Omar E, Zekry A. Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease. Semin Liver Dis. 2024 Nov;44(4):457-473. PMID: 393389571.

Prince D, Hoque S, Kim C, Maher S et al.  Cirrhosis in primary practice: many patients remain potentially undiagnosed and are not receiving liver cancer surveillance. J Gastroenterol Hepatol. 2024 Oct 24. Epub ahead of print. PMID: 39444308.

Prince D, Hoque S, Kim C, Maher S et al.  Screening patients in general practice for advanced chronic liver disease using an innovative IT solution: The Liver Toolkit. Hepatol Commun. 2024 Jun 27;8(7):e0482. PMID: 38934697

Maher S, Kabir A, Behary J, et al. IDDF2023-ABS-0020 Shifting patterns of hepatocellular carcinoma mortality risk: the impact of socioeconomic status and ethnicity in NSW, Australia. Gut 2023;72:A21-A22

Maher S, Thilakanathan C, Behary J, Zekry A. Contribution of non-viral aetiologies of liver disease to the growing burden of hepatocellular carcinoma in New South Wales. Poster Abstracts. Hepatology 74():p 157-1288, October 2021.

Maher S, Rolls S, Pavendranathan G, Akon C et al.  Virtual clinic for positive faecal occult blood tests enhances early access to bowel cancer screening and is well received by patients. Intern Med J. 2022 Sep;52(9):1525-1530. PMID: 34219337.

Maher S, Dowdell L, Zhang L, Zekry A. Community screening identifies undiagnosed chronic liver disease in high-risk populations. J Gastroenterol Hepatol. 2021 Aug;36(8):2255-2260. PMID: 33638251.

View less